BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25687359)

  • 1. Impact of polymerase chain reaction testing on Clostridium difficile infection rates in an acute health care facility.
    Murad YM; Perez J; Nokhbeh R; Ybazeta G; Dewar B; Lefebvre S; Diaz-Mitoma F
    Am J Infect Control; 2015 Apr; 43(4):383-6. PubMed ID: 25687359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
    Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
    Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
    Longtin Y; Trottier S; Brochu G; Paquet-Bolduc B; Garenc C; Loungnarath V; Beaulieu C; Goulet D; Longtin J
    Clin Infect Dis; 2013 Jan; 56(1):67-73. PubMed ID: 23011147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
    Baker I; Leeming JP; Reynolds R; Ibrahim I; Darley E
    J Hosp Infect; 2013 Aug; 84(4):311-5. PubMed ID: 23831282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections.
    Hernández-Rocha C; Barra-Carrasco J; Álvarez-Lobos M; Paredes-Sabja D; Guzmán-Durán AM
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):361-5. PubMed ID: 23415540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection.
    Berry N; Sewell B; Jafri S; Puli C; Vagia S; Lewis AM; Davies D; Rees E; Ch'ng CL
    J Hosp Infect; 2014 Jun; 87(2):109-14. PubMed ID: 24795170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
    Catanzaro M; Cirone J
    Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions.
    Kociolek LK; Patel SJ; Zheng X; Todd KM; Shulman ST; Gerding DN
    Pediatr Infect Dis J; 2016 Feb; 35(2):157-61. PubMed ID: 26517329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detection dog to identify patients with Clostridium difficile infection during a hospital outbreak.
    Bomers MK; van Agtmael MA; Luik H; Vandenbroucke-Grauls CM; Smulders YM
    J Infect; 2014 Nov; 69(5):456-61. PubMed ID: 24973552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm.
    Beaulieu C; Dionne LL; Julien AS; Longtin Y
    Clin Microbiol Infect; 2014 Oct; 20(10):1067-73. PubMed ID: 24813402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.
    Truong C; Schroeder LF; Gaur R; Anikst VE; Komo I; Watters C; McCalley E; Kulik C; Pickham D; Lee NJ; Banaei N
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):365-370. PubMed ID: 28087170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.
    Guerrero DM; Chou C; Jury LA; Nerandzic MM; Cadnum JC; Donskey CJ
    Clin Infect Dis; 2011 Aug; 53(3):287-90. PubMed ID: 21765078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.